News
Trastuzumab deruxtecan approved to treat adults with HER2-positive cancer that’s spread or can’t be removed by surgery.
A New Jersey mother who drowned her two children last year for "religious reasons" was found not guilty by reason of insanity ...
Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.
Hormone receptor (HR)-positive HER2-negative advanced breast cancer is incurable and the aim of treatment is to delay it getting worse and extend how long people live. If the cancer has alterations in ...
That has prompted the trial investigators to suggest that Enhertu could become a new standard of care for patients with HER2-low- and HER2-ultra-low-expressing tumours following endocrine therapy ...
with trials like CLEOPATRA and STOP-HER2 indicating potential for long-term survival. Future research may reshape treatment paradigms, incorporating new antibody-drug conjugates and refining ...
Researchers gave the HER2-directed dendritic cell vaccine before ... "This approach may offer a new way to enhance breast cancer treatment and patient outcomes." The study also found that ...
A New Jersey woman who drowned her two children last year for "religious reasons" was found not guilty by reason of insanity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results